LifeMD (NASDAQ:LFMD – Get Free Report) and Labcorp (NYSE:LH – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, valuation and risk.
Profitability
This table compares LifeMD and Labcorp’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| LifeMD | 2.37% | -150.88% | -22.59% |
| Labcorp | 6.66% | 16.29% | 7.62% |
Valuation & Earnings
This table compares LifeMD and Labcorp”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| LifeMD | $194.05 million | 1.14 | $14.35 million | $0.05 | 91.20 |
| Labcorp | $13.95 billion | 1.52 | $876.50 million | $11.29 | 22.98 |
Labcorp has higher revenue and earnings than LifeMD. Labcorp is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
LifeMD has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500. Comparatively, Labcorp has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent recommendations for LifeMD and Labcorp, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| LifeMD | 1 | 1 | 8 | 0 | 2.70 |
| Labcorp | 0 | 3 | 8 | 0 | 2.73 |
LifeMD presently has a consensus price target of $9.14, suggesting a potential upside of 100.50%. Labcorp has a consensus price target of $308.00, suggesting a potential upside of 18.71%. Given LifeMD’s higher possible upside, equities analysts clearly believe LifeMD is more favorable than Labcorp.
Institutional & Insider Ownership
35.5% of LifeMD shares are owned by institutional investors. Comparatively, 95.9% of Labcorp shares are owned by institutional investors. 18.4% of LifeMD shares are owned by company insiders. Comparatively, 0.8% of Labcorp shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
Labcorp beats LifeMD on 9 of the 13 factors compared between the two stocks.
About LifeMD
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with MarketBeat.com's FREE daily email newsletter.
